TECHNOLOGY
Learn More About BIS
Watch a short video that explains the technology
L-Dex® Analysis for Lymphedema
Offer your patients peace of mind. Know their L‑Dex score with the leading technology for point-of-care lymphedema assessment.
L-Dex: Designed for Early Lymphedema Detection
Lymphedema is rarely diagnosed until a patient experiences symptoms like pain, tightness,or swelling in their limb. However, with early diagnosis and intervention, the condition can be well managed1-3
- The L-Dex score, only available from ImpediMed, is designed to detect small lymphedema-related fluid changes in the limbs.
- The L-Dex score represents the difference in the amount of extracellular fluid in an at-risk limb compared to an unaffected limb.
L-Dex Analysis: Powered by Bioimpedance Spectroscopy (BIS)
L-Dex Analytics: Effectively Tracks and Trends Patient L-Dex Scores
L-Dex analytics allows healthcare professionals to easily capture and visualize a patient’s pretreatment baseline L-Dex score and any follow up measurements.
An L-Dex increase of 6.5 or more from baseline is an indication that lymphedema is developing, and intervention is needed.
Consistent monitoring with L-Dex Analytics can give patients peace of mind, offering clear outputs of lymphedema-related fluid changes in the limbs.
References
- 1. Ridner SH, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology 2022.